Helix BioPharma Corp.

TSX:HBP.TO

Biotechnology

Healthcare
$0.86 -4.70%

-$0.07 today

Market cap
$65.69M
Beta
-0.29
P/E (TTM)
-32.6
EPS (TTM)
-$0.04
52W Low $0.84High $5.40

Volume 0.00M

Average 0.00M

Balance Sheet

Inspect the capital base behind the business.

Assets

$18.80M

FY 2025 · Annual

+1162.7% YoY

Liabilities

$3.22M

FY 2025 · Annual

+103.7% YoY

Equity

$15.59M

FY 2025 · Annual

Balance Sheet

CAD
Metric
FY2021
Jul 2021
FY2022
Jul 2022
FY2023
Jul 2023
FY2024
Jul 2024
FY2025
Jul 2025
Cash & Equivalents3.57M3.25M808K1.08M65K
Short-term Investments00000
Net Receivables353K279K62K54K121K
Inventory0164K000
Other Current Assets0000223K
Total Current Assets4.02M3.7M996K1.46M409K
Property, Plant & Equipment (Net)47K35K33K33K4K
Goodwill00000
Intangible Assets0001K18.39M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets000(1K)0
Total Non-current Assets47K35K33K33K18.39M
Total Assets4.07M3.73M1.03M1.49M18.8M
Account Payables1.47M599K493K855K0
Short-term Debt2.03M2.47M00335K
Tax Payables00000
Deferred Revenue0345K000
Other Current Liabilities0(1K)998K02.88M
Total Current Liabilities3.87M3.41M1.87M1.58M3.22M
Long-term Debt1.58M0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities1.58M0(1K)00
Total Liabilities5.46M3.41M1.87M1.58M3.22M
Common Stock139.66M147.51M152.07M158.57M179.29M
Retained Earnings(188.55M)(195.12M)(201.41M)(210.67M)(215.88M)
Accumulated OCI19.63M10.34M4.36M4.65M3.87M
Other Stockholders Equity0004.65M0
Minority Interest00000
Total Equity(1.39M)319K(844K)(90K)15.59M
Total Debt3.61M2.47M00335K
Net Debt47K(784K)(808K)(1.08M)270K

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$2.8M
Receivables$28.0K
Other Current$122.0K
Total Current Assets$3.0M
PP&E (Net)$1.0K
Intangible Assets$18.4M
Total Non-current Assets$18.4M
Total Assets$21.4M

Analysis

Selected assets total $21.4M for Latest. The largest visible component is Intangible Assets at $18.4M, about 86.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does HBP.TO have?

Helix BioPharma Corp. (HBP.TO) reported $65,000.00 in cash and equivalents in fiscal 2025.

How much debt does HBP.TO carry?

Helix BioPharma Corp. (HBP.TO) reported $335,000.00 of total debt, with net debt of $270,000.00.